The grant opportunity RFA-PS-18-000 is offered by the Centers for Disease Control and Prevention (CDC), a major component of the U.S. Department of Health and Human Services. Known for its pivotal role in public health research and interventions, the CDC advances efforts to protect health and promote quality of life through the prevention and control of disease, injury, and disability. This particular funding opportunity is managed by CDC’s Extramural Research Awards (ERA) division, indicating a cooperative agreement mechanism that entails substantial involvement by the CDC in the project execution.
This opportunity supports state, academic, non-profit, and business entities in undertaking research and programmatic activities under the category of Health, specifically targeting injury prevention and control. The funding is administered under Assistance Listing 93.136, indicating alignment with injury prevention research and community-based public health programs. While the specific thematic focus of the grant is not fully described in the brief announcement, Type 6 Applications are mentioned, typically indicating supplements or continuations to existing projects, suggesting this opportunity may be linked to ongoing initiatives or be designed for incremental advancements rather than new projects.
There are no matching or cost-sharing requirements associated with this grant, which may lower the barrier for participation among smaller or less resourced entities. The expected number of awards is approximately 100, although no individual award amount is specified, and both the award floor and ceiling are listed as zero, indicating that this data may be incomplete or pending further guidance in a full Notice of Funding Opportunity (NOFO).
Eligible applicants include a wide array of organizations such as state governments, universities, counties, small businesses, and nonprofit entities. However, eligibility is generically stated and would require verification against a full NOFO for specific constraints or prioritization. The submission process appears to be standard through Grants.gov, and there is no mention of Letters of Intent or other pre-application gating steps.
The current closing date for applications is September 30, 2030, with the original closing date listed as October 13, 2025. The opportunity is thus still open and likely reflects a multi-year or ongoing application window. Recurrence is implied through the structure of Type 6 application support and the presence of a new close date, which signals a reissuance or program continuation. Contact for further information is available via Linton C Browning, the designated Grants Management Specialist, providing a direct line and email for applicant inquiries. A detailed NOFO or RFA is not linked, and further details would likely be found through direct engagement with the grantor or the CDC’s grants portal.
